In focus · trending topic

IL-6 Inhibitors Therapeutics

1 stories · following the connections

Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline Driven by Positive Clinical Results of Drug Candidates: P&S Market Research

By Nasdaq OMXFeb 6, 2018, 9:30 AM UTC